nach oben

Tumor Biology

Erschienen in:

04.08.2016 | Original Article

MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer

verfasst von: Guiqi Wang, Jingfeng Gu, Yingchao Gao

Erschienen in: Tumor Biology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Cysteine-rich protein 61 (CYR61) and metastasis associated in colon cancer (MACC1) protein promoted human colorectal cancer (CRC) cell metastasis and closely related to the patient’s prognosis in colorectal cancer. The purpose of this article is to investigate whether CYR61 and MACC1 can serve as dual potential targets for gene therapy of human CRC. In this study, microRNA (miRNA) targeting for both CYR61 and MACC1 was used to investigate the mechanism and therapeutic effects for CRC cells and mice with CRC. We observed that silencing miRNA for CYR61 and MACC1 inhibited the epithelial-mesenchymal transition (EMT) process, and co-treatment strengthened this effect. MTT assay showed that the growth of colorectal tumor cells was decreased due to miRNA treatment. Apoptosis assay revealed that miRNA for CYR61 and MACC1 promoted CRC cells apoptotic. The animals’ study results showed that the expression levels of CYR61 and MACC1 were significantly decreased after miRNA-100 and miRNA-143 treatment, respectively. The expression levels of apoptosis-promoting protein were increased significantly after treatment with miRNA-100 and miRNA-143, which suggested that both miRNA-100 and miRNA-143 may induce apoptosis by mitochondria-dependent pathway. In addition, metastasis and invasion assays showed that miRNA-100 and miRNA-143 treatment inhibited obviously migratory and invasive abilities of CRC cells. Furthermore, our data also showed that the tumor growth was significantly inhibited and survival rate of tumor-bearing mice was greatly improved by common treatments of miRNA-100 and miRNA-143. In conclusion, the abilities of apoptosis, metastasis, and invasion in CRC tumor cells were significantly suppressed by miRNA-100 and miRNA-143 targeting CYR61 and MACC1, respectively. As a result, CYR61 and MACC1 may serve as potential targets for gene therapy in human CRC treatments.

Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA: a cancer journal for clinicians. 2014;64:104–17.

Chibaudel B, Bonnetain F, Tournigand C, de Gramont A. Maintenance treatment in metastatic colorectal cancer. The lancet oncology. 2015;16:e583–584.CrossRefPubMed

Moilanen JM, Kokkonen N, Loffek S, Vayrynen JP, Syvaniemi E, Hurskainen T, et al. Collagen XVII expression correlates with the invasion and metastasis of colorectal cancer. Human pathology. 2015;46:434–42.CrossRefPubMed

Fan Z, Cui H, Xu X, Lin Z, Zhang X, Kang L, et al. Mir-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting stat3. Oncotarget. 2015;6:25266–80.CrossRefPubMedPubMedCentral

Zhang XB, Song L, Wen HJ, Bai XX, Li ZJ, Ma LJ. Upregulation of microRNA-31 targeting integrin alpha5 suppresses tumor cell invasion and metastasis by indirectly regulating pi3k/akt pathway in human gastric cancer sgc7901 cells. Tumour Biol. 2016;37(6):8317–25.CrossRefPubMed

Guo J, Yu X, Gu J, Lin Z, Zhao G, Xu F, et al. Regulation of cxcr4/akt-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer. Tumour Biol 2016;37(5):6371–8.

Jiang N, Deng JY, Liu Y, Ke B, Liu HG, Liang H. Incorporation of perineural invasion of gastric carcinoma into the 7th edition tumor-node-metastasis staging system. Tumour Biol. 2014;35:9429–36.CrossRefPubMed

Bukurova Iu A, Khankin SL, Krasnov GS, Grigor’eva ES, Mashkova TD, Lisitsin NA, et al. Comparison of 2D analysis and bioinformatics search efficiency for colon cancer marker identification. Molekuliarnaia biologiia. 2010;44:375–81.PubMed

Thompson BA, Goldgar DE, Paterson C, Clendenning M, Walters R, Arnold S, et al. A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the colon cancer family registry. Human mutation. 2013;34:200–9.CrossRefPubMed

10.

He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nature reviews Genetics. 2004;5:522–31.CrossRefPubMed

11.

Chen Y, Wakili R, Xiao J, Wu CT, Luo X, Clauss S, et al. Detailed characterization of microRNA changes in a canine heart failure model: relationship to arrhythmogenic structural remodeling. Journal of molecular and cellular cardiology. 2014;77:113–24.CrossRefPubMed

12.

Santos-Carballal B, Aaldering LJ, Ritzefeld M, Pereira S, Sewald N, Moerschbacher BM, et al. Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to mcf-7 breast cancer cells. Scientific reports. 2015;5:13567.CrossRefPubMedPubMedCentral

13.

Ozek NS, Tuna S, Erson-Bensan AE, Severcan F. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy. The Analyst. 2010;135:3094–102.CrossRefPubMed

14.

Busacca S, Germano S, De Cecco L, Rinaldi M, Comoglio F, Favero F, et al. MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications. American Journal of Respiratory Cell and Molecular Biology. 2010;42:312–9.CrossRefPubMed

15.

Zhang W, Zhang J, Yan W, You G, Bao Z, Li S, et al. Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme. Cancer. 2013;119:814–24.CrossRefPubMed

16.

Konishi H, Fujiya M, Ueno N, Moriichi K, Sasajima J, Ikuta K, et al. MicroRNA-26a and -584 inhibit the colorectal cancer progression through inhibition of the binding of HNRNP A1-CDK6 mRNA. Biochemical and biophysical research communications. 2015;467:847–52.CrossRefPubMed

17.

Fei BY, Wang XY, Fang XD. MicroRNA-143 replenishment re-sensitizes colorectal cancer cells harboring mutant, but not wild-type, kras to paclitaxel treatment. Tumour Biol. 2016;37(5):5829–35.

18.

Xu ST, Ding X, Ni QF, Jin SJ. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in t24 cells. International journal of clinical and experimental pathology. 2015;8:7937–44.PubMedPubMedCentral

19.

Han S, Bui NT, Ho MT, Kim YM, Cho M, Shin DB. Dexamethasone inhibits tgf-beta1-induced cell migration by regulating the erk and akt pathways in human colon cancer cells via CYR61. Cancer Res Treat. 2016;48(3):1141–53.

20.

Haque I, Banerjee S, Mehta S, De A, Majumder M, Mayo MS, et al. Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (ccn5)/WNT-1-induced signaling protein-2 (wisp-2) regulates microRNA-10b via hypoxia-inducible factor-1alpha-twist signaling networks in human breast cancer cells. The Journal of biological chemistry. 2011;286:43475–85.CrossRefPubMedPubMedCentral

21.

Osaki M, Inaba A, Nishikawa K, Sugimoto Y, Shomori K, Inoue T, et al. Cysteine-rich protein 61 suppresses cell invasion via down-regulation of matrix metalloproteinase-7 expression in the human gastric carcinoma cell line mkn-45. Molecular medicine reports. 2010;3:711–5.CrossRefPubMed

22.

Sun ZJ, Wang Y, Cai Z, Chen PP, Tong XJ, Xie D. Involvement of CYR61 in growth, migration, and metastasis of prostate cancer cells. British journal of cancer. 2008;99:1656–67.CrossRefPubMedPubMedCentral

23.

Sun L, Duan J, Jiang Y, Wang L, Huang N, Lin L, et al. Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-c/d to promote lymphangiogenesis in human gastric cancer. Cancer letters. 2015;357:242–53.CrossRefPubMed

24.

Lederer A, Herrmann P, Seehofer D, Dietel M, Pratschke J, Schlag P, et al. Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in Klatskin tumor patients. Hepatology. 2015;62:841–50.CrossRefPubMed

25.

Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, et al. Macc1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nature medicine. 2009;15:59–67.CrossRefPubMed

26.

Boardman LA. Overexpression of MACC1 leads to downstream activation of hgf/met and potentiates metastasis and recurrence of colorectal cancer. Genome medicine. 2009;1:36.CrossRefPubMedPubMedCentral

27.

Shimokawa H, Uramoto H, Onitsuka T, Chundong G, Hanagiri T, Oyama T, et al. Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence. The Journal of thoracic and cardiovascular surgery. 2011;141:895–8.CrossRefPubMed

28.

Migliore C, Martin V, Leoni VP, Restivo A, Atzori L, Petrelli A, et al. Mir-1 downregulation cooperates with MACC1 in promoting met overexpression in human colon cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2012;18:737–47.CrossRef

29.

Yang T, Kong B, Kuang YQ, Cheng L, Gu JW, Zhang JH, et al. Overexpression of MACC1 protein and its clinical implications in patients with glioma. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35:815–9.CrossRef

30.

Wang Z, Li Z, Wu C, Wang Y, Xia Y, Chen L, et al. Macc1 overexpression predicts a poor prognosis for non-small cell lung cancer. Med Oncol. 2014;31:790.CrossRefPubMed

31.

Wang G, Fu Z, Li D. Macc1 overexpression and survival in solid tumors: a meta-analysis. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36:1055–65.CrossRef

32.

Li H, Zhang H, Zhao S, Shi Y, Yao J, Zhang Y, et al. Overexpression of MACC1 and the association with hepatocyte growth factor/c-met in epithelial ovarian cancer. Oncology letters. 2015;9:1989–96.PubMedPubMedCentral

33.

Da Ros VG, Gutierrez-Perez I, Ferres-Marco D, Dominguez M. Dampening the signals transduced through hedgehog via microRNA MIR-7 facilitates notch-induced tumourigenesis. PLoS biology. 2013;11:e1001554.CrossRefPubMedPubMedCentral

34.

Wai-Hoe L, Wing-Seng L, Ismail Z, Lay-Harn G. Sds-page-based quantitative assay for screening of kidney stone disease. Biological procedures online. 2009;11:145–60.CrossRefPubMedPubMedCentral

35.

Bai FL, Yu YH, Tian H, Ren GP, Wang H, Zhou B, et al. Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy. Cancer Biology & Therapy. 2014;15:1226–38.CrossRef

36.

Yang L, Wu X, Liu F, Duan Y, Li S. Novel biodegradable polylactide/poly(ethylene glycol) micelles prepared by direct dissolution method for controlled delivery of anticancer drugs. Pharmaceutical research. 2009;26:2332–42.CrossRefPubMed

37.

Zhang Y, Wang Z, Chen M, Peng L, Wang X, Ma Q, et al. MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Molecular cancer. 2012;11:23.CrossRefPubMedPubMedCentral

38.

Zhang Y, Diao Z, Su L, Sun H, Li R, Cui H, et al. MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am J Obstet Gynecol. 2010;202:466. e461-467.CrossRefPubMed

39.

Pichler M, Calin GA. MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. British journal of cancer. 2015;113:569–73.CrossRefPubMedPubMedCentral

40.

Pooja T, Karunagaran D. Emodin suppresses WNT signaling in human colorectal cancer cells sw480 and sw620. European Journal of Pharmacology. 2014;742:55–64.CrossRefPubMed

41.

Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad O. Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer. 2004;40:1593–8.CrossRefPubMed

42.

Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids—the mix of hormones and biomarkers. Nature reviews Clinical oncology. 2011;8:467–77.CrossRefPubMedPubMedCentral

43.

Isella C, Mellano A, Galimi F, Petti C, Capussotti L, De Simone M, et al. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. Annals of surgery. 2013;257:1089–95.CrossRefPubMed

44.

Nicolas FJ, Lehmann K, Warne PH, Hill CS, Downward J. Epithelial to mesenchymal transition in Madin-Darby canine kidney cells is accompanied by down-regulation of SMAD3 expression, leading to resistance to transforming growth factor-beta-induced growth arrest. The Journal of biological chemistry. 2003;278:3251–6.CrossRefPubMed

45.

Lemos C, Hardt MS, Juneja M, Voss C, Forster S, Jerchow B, et al. Macc1 induces tumor progression in transgenic mice and colorectal cancer patients via increased pluripotency markers nanog and oct4. Clin Cancer Res. 2016;22(11):2812–24.

46.

Cecchi F, Rabe DC, Bottaro DP. Targeting the hgf/met signaling pathway in cancer therapy. Expert opinion on therapeutic targets. 2012;16:553–72.CrossRefPubMedPubMedCentral

47.

Ren B, Zakharov V, Yang Q, McMahon L, Yu J, Cao W. Macc1 is related to colorectal cancer initiation and early-stage invasive growth. American journal of clinical pathology. 2013;140:701–7.CrossRefPubMed

48.

Ladwa R, Pringle H, Kumar R, West K. Expression of CTGF and CYR61 in colorectal cancer. Journal of clinical pathology. 2011;64:58–64.CrossRefPubMed

49.

Ilm K, Kemmner W, Osterland M, Burock S, Koch G, Herrmann P, et al. High MACC1 expression in combination with mutated kras g13 indicates poor survival of colorectal cancer patients. Molecular cancer. 2015;14:38.CrossRefPubMedPubMedCentral

50.

Jeong D, Heo S, Sung Ahn T, Lee S, Park S, Kim H, et al. Cyr61 expression is associated with prognosis in patients with colorectal cancer. BMC cancer. 2014;14:164.CrossRefPubMedPubMedCentral

51.

Zaharie F, Muresan MS, Petrushev B, Berce C, Gafencu GA, Selicean S, et al. Exosome-carried microRNA-375 inhibits cell progression and dissemination via bcl-2 blocking in colon cancer. Journal of gastrointestinal and liver diseases: JGLD. 2015;24:435–43.PubMed

52.

Riethmuller M, Burger N, Bauer G. Singlet oxygen treatment of tumor cells triggers extracellular singlet oxygen generation, catalase inactivation and reactivation of intercellular apoptosis-inducing signaling. Redox biology. 2015;6:157–68.CrossRefPubMedPubMedCentral

53.

Sampath D, Winneker RC, Zhang Z. Cyr61, a member of the ccn family, is required for mcf-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer. Endocrinology. 2001;142:2540–8.PubMed

54.

Huang Y, Zhang H, Cai J, Fang L, Wu J, Ye C, et al. Overexpression of MACC1 and its significance in human breast cancer progression. Cell & Bioscience. 2013;3:16.CrossRef

55.

Lin L, Huang H, Liao W, Ma H, Liu J, Wang L, et al. Macc1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect. Oncogene. 2015;34:2700–10.CrossRefPubMed

56.

Simmer F, Venderbosch S, Dijkstra JR, Vink-Borger EM, Faber C, Mekenkamp LJ, et al. MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer. Oncotarget. 2015;6:22996–3007.CrossRefPubMedPubMedCentral

57.

Zhang S, Yuan W, Tang W, Xu C, Ma J. Expression of microRNA-100 and its relation with prognosis of colorectal cancer. Zhonghua zhong liu za zhi Chinese J Oncol 2015;37:603-608.

Titel: MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer
verfasst von: Guiqi Wang
Jingfeng Gu
Yingchao Gao
Publikationsdatum: 04.08.2016
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 10/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-016-5252-2

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2016

Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value

Parallel targeted next generation sequencing of childhood and adult acute myeloid leukemia patients reveals uniform genomic profile of the disease

Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance

Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma

Ganoderic acid targeting multiple receptors in cancer: in silico and in vitro study

Oxystressed tumor microenvironment potentiates epithelial to mesenchymal transition and alters cellular bioenergetics towards cancer progression

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie